Cuba Headlines

Cuba News, Breaking News, Articles and Daily Information

Cuba´s Genetic Engineering and Biotechnology Center (CIGB) will carry out medical trials on a medication against chronic hepatitis B and C.

  This interferon has a broader effect and reduces the intake dosage, Hugo Nodarse, head of the CIGB Oncology Research Department, told Juventud Rebelde daily at the National Workshop on the Use of Biotechnological Products to Treat Viver Disorders, held on Friday in Havana´s Center for Medical Surgery Research (CIMEQ).

In this regard, Nodarse mentioned the successful administration of PEG-Heberón to treat hepatitis B and C, and opportunistic infections in AIDS/HIV patients.

Specialist Pedro Lopez highlighted the successful three-decade research that resulted in a vaccine against hepatitis B, whose distribution eradicated the disease among children.

Fuente: Prensa Latina

Related News